Table 1.
Randomised controlled trials (RCTs) compared with non-randomised controlled trials (non-RCTs) of the same intervention
Study | Sample (search strategy) | Comparison | Results | Direction of bias |
---|---|---|---|---|
Chalmers 19777 | 32 controlled studies of anticoagulation in acute myocardial infarction (systematic) | RCTs with CCTs and HCTs on case fatality rate, rate of thromboembolism, and haemorrhages | Relative risk reduction for mortality overestimated by 35% in HCTs and 6% in CCTs compared with RCTs. Case fatality rate highest in HCTs (38.3%) compared with RCTs (19.6%) and CCTs (29.2%). Similar pattern for thromboembolism | Overestimation of effect |
Sacks 19828 | Sample of 50 RCTs and 56 HCTs, assessing 6 interventions (treatment of oesophageal varices, coronary artery surgery, anticoagulation in myocardial infarction, chemotherapy for colon cancer and melanoma, and diethylstilboestrol for recurrent miscarriage) (at hand) | RCTs with HCTs on frequency of detecting statistically significant results (P⩽0.05) of primary outcome and reduction of mortality | 20% of the RCTs found a statistically significant benefit from the new treatment compared with 79% of the HCTs. Relative risk reduction of mortality in HCTs v RCTs was 0.49/0.27 (1.8) for cirrhosis, 0.68/0.26 (2.6) for coronary artery surgery at 3 years, 0.49/0.22 (2.2) for anticoagulation in myocardial infarction, and 0.67/−0.02 for diethylstilboestrol in recurrent miscarriage. Outcomes in treatment groups were similar in both designs, but outcomes in control groups were worse among historical controls | Overestimation of effect |
Diehl 19869 | 19 RCTs and 17 HCTs for 6 types of cancer (breast, colon, stomach, lung cancer, melanoma, soft tissue sarcoma) (reference lists of two textbooks) | Matching of randomised and historical controls for disease, stage, and follow up, and comparison on survival and relapse free survival | 18 of 43 matched control groups (42%) varied by >10% (absolute difference in either outcome), 9 (21%) by >20%, and 2 (5%) by >30%. Survival or relapse free survival was better in RCTs compared with HCTs in 17/18 matches | Overestimation of effect |
Reimold 199210 | 6 RCTs and 6 CCTs of chinidine in atrial fibrillation (systematic) | RCTs and CCTs on maintenance of sinus rhythm 3, 6, and 12 months after cardioversion | At 3 months, beneficial effect of maintaining sinus rhythm with chinidine was 54% less in non-RCTs compared with RCTs, and was 76% less at 12 months | Underestimation of effect |
Recurrent Miscarriage Immunotherapy Trialists Group 199411 | 9 RCTs and 6 CCTs (with self selected treatment) of allogenic leucocyte immunotherapy for recurrent miscarriage (systematic) | RCTs and CCTs on live birth rate | Beneficial effect of immunotherapy on birth rate among pregnant women was 9% larger in CCTs compared with RCTs, but was 63% lower in CCTs when all women were considered | Underestimation of effect when all women considered, similar effect for pregnant women |
Watson 199412 | 4 RCTs and 6 CCTs/HCTs of oil soluble contrast media during hysterosalpingography in infertile couples (systematic) | RCTs and CCTs/HCTs on pregnancy rate | RCTs and CCTs/HCTs detected similar increases in pregnancy rates: odds ratio for RCTs 1.92 (95% CI, 1.33 to 2.68) and for CCTs/HCTs 1.92 (1.55 to 2.38) | Similar effect |
Pyörälä 199513 | 11 RCTs and 22 (not further specified) non-RCTs on hormonal therapy in cryptorchidism (systematic) | RCTs and non-RCTs on the descent of testes after therapy with luteinising hormone releasing hormone or human chorionic gonadotrophin | Success rate of descent of testes after therapy with luteinising hormone releasing hormone was 2.3 times larger in non-RCTs than in RCTs and 1.7 times larger after therapy with human chorionic gonadotrophin | Overestimation of effect |
Carroll 199614 | 17 RCTs and 19 non-RCTs (including HCTs or trials with inadequate randomisation procedures) on transcutaneous electrical nerve stimulation (systematic) | RCTs and non-RCTs on control of postoperative pain | Transcutaneous electrical nerve stimulation judged ineffective at improving postoperative pain in 85% of RCTs, while 89% of non-RCTs concluded that it did improve postoperative pain | Overestimation of effect |
CCT=concurrently controlled trial; HCT=historically controlled trial.